Additionally, as shown in Figure 5B, high ZNF433 expression in ESCA and PRAD was linked to poorer DFS (P < 0.05), while high expression in BRCA, KIRC, KIRP, and THYM was associated with better DFS (P < 0.05). The gene discussed is ZNF433; the disease is prostate adenocarcinoma.